Defining regulators of immunity to acute infection using CRISPR screens — Arlene H. Sharpe (HARVARD MEDICAL SCHOOL)
The overarching goal of this U19 Program is to use forward genetic screens in mice to advance our understanding of immune responses to pathogens. This U19 Program is driven by our recent development o
| Project title | Defining regulators of immunity to acute infection using CRISPR screens |
|---|---|
| Project number | 5U19AI133524-05 |
| PI name | Arlene H. Sharpe |
| Institution | HARVARD MEDICAL SCHOOL |
| Funding mechanism | U19 |
| Agency | NIAID |
| Award amount | $2.29M |
| Fiscal year | 2021 |
| Project start | 2017-07-05T00:00:00 |
| Project end | 2023-06-30T00:00:00 |
| Abstract | The overarching goal of this U19 Program is to use forward genetic screens in mice to advance our understanding of immune responses to pathogens. This U19 Program is driven by our recent development o |
| Key terms | <Allergy><Autoimmune Status><Autoimmunity><Bio-Informatics><Bioinformatics><Boston><CD4 Cells><CD4 P |
$799/mo
Try GrantRadar →